Cite

HARVARD Citation

    Su, J. et al. (2017). Inhibition of IL-17 might be a novel therapeutic target in the treatment of myocardial ischemia reperfusion injury. International journal of cardiology. pp. 29-. [Online]. 
  
Back to record